Rock Springs Capital Management LP Q1 2020 Filing

Filed May 15, 2020

Portfolio Value

$2.4B

Holdings

131

Report Date

Q1 2020

Filing Type

13F-HR

All Holdings (131 positions)

StockValue
PARATEK PHARMACEUTICALS INC
$4.8M
AKROAKERO THERAPEUTICS INC
$4.8M
GRTXGALERA THERAPEUTICS INC
$4.8M
TXG10X GENOMICS INC
$4.7M
NGMUSDNGM BIOPHARMACEUTICALS INC
$4.3M
OSWONESPAWORLD HOLDINGS LIMITED
$4.3M
ANABANAPTYSBIO INC
$4.2M
IMVTIMMUNOVANT INC
$3.9M
MYOVANT SCIENCES LTD
$3.8M
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
$3.7M
PHASEBIO PHARMACEUTICALS INC
$3.7M
PASGPASSAGE BIO INC
$3.5M
OBSEVA SA
$3.4M
ADAPYADAPTIMMUNE THERAPEUTICS PLC
$3.3M
AXNX*AXONICS MODULATION TECHNOLOG
$3.2M
TREURTRILLIUM THERAPEUTICS INC
$3.0M
GAMIDA CELL LTD
$3.0M
GLOBAL CORD BLOOD CORPORATIO
$2.9M
GW PHARMACEUTICALS PLC
$2.6M
TVTX 2.5 09/15/25RETROPHIN INC
$2.6M
ACRSACLARIS THERAPEUTICS INC
$1.7M
XLRNACCELERON PHARMA INC
$1.6M
THERAVANCE BIOPHARMA INC
$1.4M
MGNXMACROGENICS INC
$1.3M
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC
$1.3M
RADIUS HEALTH INC
$1.1M
PACIRA BIOSCIENCES
$966K
FIVE PRIME THERAPEUTICS INC
$908K
BMY-RBRISTOL-MYERS SQUIBB CO
$704K
NABRIVA THERAPEUTICS PLC
$604K
CVETUSDCOVETRUS INC
$168K
PreviousPage 2 of 2